Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pyrethroid-induced paresthesia--a central or local toxic effect?

M F Wilks1

  • 1Medical Toxicology Unit, Guy's & St. Thomas' Hospital Trust, London, United Kingdom. Martin.Wilks@gstt.sthames.nhs.uk

Journal of Toxicology. Clinical Toxicology
|April 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.

Nanotoxicology·2018
Same author

White paper on the promotion of an integrated risk assessment concept in European regulatory frameworks for chemicals.

The Science of the total environment·2015
Same author

Bisphenol A--Why an adverse outcome pathway framework needs to be applied.

Toxicology letters·2014
Same author

Neurodevelopmental and neurobehavioural effects of polybrominated and perfluorinated chemicals: a systematic review of the epidemiological literature using a quality assessment scheme.

Toxicology letters·2014
Same author

With the benefit of hindsight: trials using retrospective controls versus randomized controlled trials in clinical toxicology.

Clinical toxicology (Philadelphia, Pa.)·2013
Same author

Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis.

The Science of the total environment·2013

Pyrethroid exposure can cause temporary skin sensations like burning or tingling, primarily on the face. These effects are localized, occur at low doses, and can be prevented with proper hygiene and protective measures.

Area of Science:

  • Toxicology
  • Dermatology
  • Neuroscience

Background:

  • Dermal exposure to pyrethroids commonly results in paresthesia, characterized by sensations of burning, tingling, itching, or numbness.
  • These symptoms typically manifest on the face within 1-2 hours of exposure and resolve spontaneously.

Purpose of the Study:

  • To elucidate the mechanisms behind pyrethroid-induced paresthesia.
  • To characterize the dose-response relationship and factors influencing pyrethroid-induced paresthesia.
  • To provide guidance on managing and preventing pyrethroid-induced paresthesia.

Main Methods:

  • The study focuses on the direct effects of pyrethroids on intracutaneous nerve endings.
  • Analysis of pyrethroid potency, particularly the influence of the alpha-cyano group, on the occurrence and severity of paresthesia.

Related Experiment Videos

Main Results:

  • Pyrethroid-induced paresthesia results from direct interaction with nerve endings in the skin at low exposure doses.
  • The intensity of paresthesia correlates with pyrethroid potency; compounds lacking an alpha-cyano group exhibit weaker effects.
  • Doses causing paresthesia are significantly lower than those associated with systemic or central nervous system toxicity.

Conclusions:

  • Pyrethroid-induced paresthesia is a localized and generally benign effect, considered a nuisance rather than a toxicological concern.
  • Preventive measures, including appropriate hygiene and personal protective equipment, are the most effective strategies for individuals exposed to pyrethroids.